Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions ...
From shrinking drug development timelines to scouting potential acquisitions, the recent run of first-quarter earnings results marked a shift for Big Pharma from AI hype to explaining how the ...
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already ...
Corcept Therapeutics’ ALS drug was linked to an 87% reduction in the risk of death, a result the biotech hopes to replicate ...
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...
Men’s Health spoke to Novo Nordisk's Thomas Kruse and Jesper Lau, the two chemists responsible for discovering ...
Nanoparticle technology presents key market opportunities in drug delivery, diagnostics, and therapeutic innovations, enhancing drug efficacy and minimizing side effects. Emerging applications in ...
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company ...
La Trobe scientists have made a pivotal discovery in the fight against dangerous drug-resistant bacteria, as the University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results